Back to Journals » International Journal of Nanomedicine » Volume 14

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

Total article views   HTML views PDF downloads Totals
8,398 Dovepress* 7,764+ 1,208 8,972
PubMed Central* 634 141 775
Totals 8,398 1,349 9,747
*Since 6 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar